Shankar Siva - Publications

Does stereotactic ablative body radiotherapy (SABR) added to continued systemic therapy improve time to treatment failure compared with physician's choice of systemic therapy in oligoprogressive ER-positive, HER2-negative advanced breast cancer? Study protocol for a multicentre, randomised, open-label phase II trial in Australian tertiary cancer centres (AVATAR-II).

Journal: BMJ open

Published: September 03, 2026

Clinical outcomes of stereotactic body radiotherapy in oligometastatic disease: a national real-world cohort study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 22, 2026

Reply to Antonio Cigliola, Andrea Necchi, and Umberto Capitanio's Letter to the Editor Re: Metastasis-directed Therapy with or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.

Journal: European urology

Published: June 18, 2026

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications.

Journal: World journal of urology

Published: May 26, 2026

Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era.

Journal: The Prostate

Published: May 26, 2026

Oligometastatic RCC: Challenges and Emerging Therapeutic Strategies.

Journal: Cancers

Published: May 10, 2026

A Response to the Letter to the Editor: Radiotherapy to the Primary, With or Without Total Metastatic Ablation.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 29, 2026

Lymph Node Sampling Patterns and Completeness of Staging During Systematic Mediastinal Lymph Node Staging in Patients with Locally Advanced Non-Small-Cell Lung Cancer: A Post Hoc Analysis from the SEISMIC Study.

Journal: Cancers

Published: April 16, 2026

Synoptic Reporting Improves Quality of Endobronchial Ultrasound (EBUS): An Australian Multicentre Study.

Journal: Cancers

Published: March 31, 2026

Defining Intraprostatic Gross Tumor Volume and Micro-boosting through Consensus: A Contour-Based Modified Delphi Consensus.

Journal: International journal of radiation oncology, biology, physics

Published: March 16, 2026

Stereotactic radiotherapy for rib metastases from prostate cancer: A multicenter real-world analysis of local control, pain response, and treatment tolerance (RIBRISK).

Journal: Therapeutic advances in medical oncology

Published: March 14, 2026

Outcomes of stereotactic ablative body radiotherapy for treatment of oligometastatic gynecological cancers: a narrative review.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 11, 2026